ZBH

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Zimmer Biomet Holdings Inc

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
CEO
Bryan Hanson
Employees
20000
Headquarters

345 E Main St
Warsaw, Indiana 46580-2746
Phone: 15742676131
www.zimmerbiomet.com

News

Zimmer Biomet Holdings: Dividend Insights
Mar 23, 2023 14:45pm

Monday marks the last chance for investors to receive the next dividend payout from Zimmer Biomet Holdings (NYSE: ZBH ). What''s Happening The company announced on Wednesday that it would pay shareholders a quarterly dividend of 24 cents per share. On Tuesday, Zimmer Biomet Holdings will go ex-dividend, meaning the stock will trade lower to reflect that payout. … Full story available on Benzinga.com


Source:Benzinga
Zimmer Biomet upgraded at Piper Sandler citing conservative guidance
Mar 10, 2023 13:25pm

Zimmer Biomet (ZBH) trended higher on Friday after Piper Sandler upgraded it arguing that the company has conservative guidance amid an upbeat joint market. Read the full story here.


Source:Seeking Alpha
Piper Sandler Upgrades Zimmer Biomet to Overweight
Mar 10, 2023 07:33am

https://www.investing.com/news/pro/piper-sandler-upgrades-zimmer-biomet-to-overweight-432SI-3027112


Source:Investing.com
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2023
Mar 08, 2023 12:00pm

WARSAW, Ind., March 8, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2023. The cash…


Source:PR Newswire
Knee Braces Global Market Report 2022: Sector to Reach $2.84 Billion by 2027 at a CAGR of 6.4%
Feb 24, 2023 01:30am

DUBLIN , Feb. 23, 2023 /PRNewswire/ -- The "Global Knee Braces Market (2022-2027) by Product, Application, Delivery Channel, Type, End User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com''s offering. The Global Knee Braces Market is estimated to be USD 2.08 Bn in 2022 and is expected to reach USD 2.84 Bn by 2027, growing at a CAGR of 6.4% Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.


Source:Benzinga
Dental Barrier Membrane Bone Graft Market Is Thriving Worldwide with the Outstanding Key players by 2023: Geistlich, Zimmer Biomet, Yantai Zhenghai Bio-tech
Feb 13, 2023 10:19am

The Dental Barrier Membrane Bone Graft Market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data. The


Source:OpenPR
Handheld Surgical Devices And Equipment Global Market Report 2023
Feb 10, 2023 13:11pm

Major players in the handheld surgical devices market are B. Braun Melsungen AG, Medtronic, Smith & Nephew, Johnson & Johnson Services Inc, Integra Life Sciences Corporation, Zimmer Biomet, CooperSurgical Inc, Becton, Dickinson and Company, and Moria. Major players in the handheld surgical devices market are B. Braun Melsungen AG, Medtronic, Smith & Nephew, Johnson & Johnson Services Inc, Integra Life Sciences Corporation, Zimmer Biomet, CooperSurgical Inc, Becton, Dickinson and Company, and Moria.


Source:GlobeNewswire
Joint Reconstruction Devices And Equipment Global Market Report 2023
Feb 10, 2023 12:21pm

Major players in the joint reconstruction devices and equipment market are Smith & Nephew, Stryker, Zimmer Biomet, B. Braun Melsungen, Wright Medical Group, DePuy Synthes, Johnson & Johnson, Aesculap Implant Systems Inc, and Arthrex Inc. Major players in the joint reconstruction devices and equipment market are Smith & Nephew, Stryker, Zimmer Biomet, B. Braun Melsungen, Wright Medical Group, DePuy Synthes, Johnson & Johnson, Aesculap Implant Systems Inc, and Arthrex Inc.


Source:GlobeNewswire
Zimmer Biomet Stock: Ortho Performance Encouraging (NYSE:ZBH)
Feb 09, 2023 02:23am

Zimmer Biomet posted promising Q4 results, with revenue beats down the line and improved gross margin. Click here to read my current thoughts on ZBH stock.


Source:Seeking Alpha
Implantable Biomaterials Global Market Report 2023
Feb 08, 2023 15:58pm

Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation. Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation.


Source:GlobeNewswire
Centre Asset Management, LLC Buys 2, Sells 3 in 4th Quarter
Feb 07, 2023 18:00pm

Related Stocks: GOOG , GOOGL , RRC , ZBH , TSLA ,


Source:GuruFocus
Top 5 4th Quarter Trades of ARMSTRONG SHAW ASSOCIATES INC/CT
Feb 07, 2023 16:00pm

Related Stocks: EEM , MSFT , DIS , GILD , ZBH ,


Source:GuruFocus
Zimmer Biomet: Expect Volume To Rise As Covid Impact And Labour Stabilizes
Feb 06, 2023 23:35pm

Zimmer Biomet posted strong revenue growth in 4Q22 with organic growth of 10% and an earnings per share of $1.88. Click here to read more about ZBH stock.


Source:Seeking Alpha
Zimmer Biomet PT Raised to $142 at Oppenheimer
Feb 06, 2023 13:08pm

https://www.investing.com/news/pro/zimmer-biomet-pt-raised-to-142-at-oppenheimer-432SI-2996112


Source:Investing.com
Zimmer Biomet PT Raised to $115 at Jefferies
Feb 06, 2023 13:00pm

https://www.investing.com/news/pro/zimmer-biomet-pt-raised-to-115-at-jefferies-432SI-2996102


Source:Investing.com
Zimmer Biomet PT Raised to $137 at Truist Securities
Feb 06, 2023 12:42pm

https://www.investing.com/news/pro/zimmer-biomet-pt-raised-to-137-at-truist-securities-432SI-2996073


Source:Investing.com
Zimmer Biomet Holdings (ZBH) Q4 2022 Earnings Call Transcript
Feb 03, 2023 17:53pm

Zimmer Biomet Holdings Inc. (NYSE:NYSE:ZBH) Q4 2022 Earnings Conference Call February 3, 2023 8:30 AM ETCompany ParticipantsBryan Hanson - President, Chief Executive OfficerSuketu Upadhyay…


Source:Seeking Alpha
Zimmer Biomet Sees FY23 Profit In Line With View
Feb 03, 2023 12:48pm

WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) said it expects adjusted earnings per share to be in the range $6.95 - $7.15 and revenue growth of 1.5% - 3.5% for fiscal year 2023. Analys…


Source:Finanz Nachrichten
Zimmer Biomet earnings beat by $0.05, revenue topped estimates By Investing.com
Feb 03, 2023 11:37am

Zimmer Biomet earnings beat by $0.05, revenue topped estimates


Source:Investing.com
Zimmer Biomet Non-GAAP EPS of $1.88 beats by $0.05, revenue of $1.83B beats by $70M
Feb 03, 2023 11:34am

Zimmer Biomet press release (ZBH): Q4 Non-GAAP EPS of $1.88 beats by $0.05.Revenue of $1.83B (+3.4% Y/Y) beats by $70M.For FY2023, the company expects revenue growth of 1.5% to 3.5% vs


Source:Seeking Alpha
Zimmer Biomet Announces Fourth Quarter and Full-Year 2022 Financial Results
Feb 03, 2023 11:30am

Fourth quarter net sales from continuing operations of $1.825 billion increased 2.7% and 8.3% on a constant currency1 basis Fourth quarter diluted loss per share from continuing operations was $0.62; adjusted1 diluted earnings per share from continuing operations were $1.88 Full-year net…


Source:PR Newswire
Zimmer Biomet Q4 2022 Earnings Preview
Feb 02, 2023 17:08pm

Zimmer Biomet (ZBH) is scheduled to announce Q4 earnings results on Friday, February 3rd, before market open.The consensus EPS Estimate is $1.83 (-6.2% Y/Y) and the consensus…


Source:Seeking Alpha
Preview: Zimmer Biomet Holdings''s Earnings
Feb 02, 2023 14:01pm

Zimmer Biomet Holdings (NYSE: ZBH ) is set to give its latest quarterly earnings report on Friday, 2023-02-03. Here''s what investors need to know before the announcement. Analysts estimate that Zimmer Biomet Holdings will report an earnings per share (EPS) of $1.82. Zimmer Biomet Holdings bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, … Full story available on Benzinga.com


Source:Benzinga
Zimmer Biomet Holdings – Consensus Indicates Potential 2.1% Upside
Jan 29, 2023 13:35pm

Zimmer Biomet Holdings with ticker code (ZBH) now have 23 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 145 and 100 calculating the average target price we see 128.13. Given that the stocks previous close was at 125.5 this would indicate that there is a potential upside of 2.1%. The day 50 moving average is 123.36 and the 200 day MA is 115.21. The market cap for the company is $26,416m. Visit the company website at: https://www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $26,970m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.


Source:DirectorsTalk
Pettee Investors, Inc.''s Top 5 Sells of the 4th Quarter
Jan 25, 2023 20:00pm

Related Stocks: AMT , ZBH , INVH , FAF , J ,


Source:GuruFocus
Zimmer Biomet Holdings – Consensus Indicates Potential 5.1% Upside
Jan 23, 2023 13:06pm

Zimmer Biomet Holdings found using ticker (ZBH) have now 23 analysts covering the stock. The analyst consensus points to a rating of ''Hold''. The target price ranges between 145 and 100 with the average target price sitting at 128.13. With the stocks previous close at 121.95 this now indicates there is a potential upside of 5.1%. The 50 day MA is 121.88 and the 200 day MA is 115.29. The company has a market cap of $26,041m. Company Website: https://www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,360m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.


Source:DirectorsTalk